Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus

European Journal of Clinical Investigation

Volumn 33, Issue 8, 2003, Pages 720-725

  Verkerk, M S A ^a   Visseren, F L J ^b   Bouter, K Paul ^c   Diepersloot, Rob J A ^a  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Hepatocytes; Infection; Interleukin 6; Plasminogen activator inhibitor 1 and fibrinogen

Indexed keywords

CYTOKINE; FIBRINOGEN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE PHASE RESPONSE; ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; CELL DAMAGE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOGEN SYNTHESIS; HUMAN; HUMAN CELL; LIVER CELL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ACUTE-PHASE REACTION; CELL LINE; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS INFECTIONS; FIBRINOGEN; HEPATOCYTES; HUMANS; INTERLEUKIN-6; MICROSCOPY, PHASE-CONTRAST; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 0041664939     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01183.x     Document Type: Article

References (33)

1. Whicher J, Biasucci L, Rifai N. Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 1999;37:495-503.
2. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340:115-26.
3. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
4. Visseren FLJ, Verkerk MSA, Bouter KP, Diepersloot RJA, Erkelens DW. Interleukin-6 production by endothelial cells after infection with influenza virus and Cytomegalovirus. J Lab Clin Med 1999;134:623-30.
5. Visseren FLJ, Bouwman JJM, Bouter KP, Diepersloot RJA, de Groot PhG, Erkelens DW. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost 2000;84:319-24.
6. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T et al. Association between prior Cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.
7. Epstein SE, Speir E, Zhou YF, Guetta E, Leon MB, Finkel T. The role of infection in restenosis and atherosclerosis: focus on Cytomegalovirus. Lancet 1996;348:s13-s16.
8. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312:1061-5.
9. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989;261:3561-6.
10. Hendrix MGR, Beukel E, Slobbe RL, Bruggemans CA. Detection and sequence analysis of the major immediate early and PP150 gene of latent human cytomegalovirus in spleen, liver and kidney tissues of trauma victims. J Med Virol 1996;50:193-7.
11. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
12. Castell JV, Gomez MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by Interleukin-6. Hepatology 1990;12:1179-86.
13. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001;103:2260-5.
14. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP et al. Cardiovascular disease, interleukin-6 and risk of mortality in older women. Circulation 2001;103:947-53.
15. Yap SH, Moshage HJ, Hazenberg BPC, Roelofs HMJ, Bijzet J, Limburg PC et al. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid (SAA) in primary cultures of human hepatocytes. Biochim Biophys Acta 1991;1091:405-8.
16. Nakagomi A, Freedman SB, Geczy CL. Interferon-γ and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein. Relationship with age, sex and hormone replacement treatment. Circulation 2000;101:1785-97.
17. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages. Implications for Atherosclerosis Circulation 2001;101:1194-7.
18. Lots M, Jirik F, Kabouridis R, Tsoukas C, Hirano T, Kishimoto T et al. IL-6 is co-stimulant for human thymocytes and T-lymphocytes. J Exp Med 1988;140:508-13.
19. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T et al. Complementary DNA for novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobin. Nature 1986;324:73-7.
20. Mule JJ, McIntosh JF, Joblons DM, Rosenberg SA. Antitumor activity of recombinant interleukin-6 in mice. J Exp Med 1990;171:629-35.
21. Cauldie JC, Richards C, Harnich D, Lansdrop P, Baumann H. Interferon b2/BSF-2 shares identity with monocyte-derived hepatocytes stimulating factor (HSF) and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A 1987;84:7251-6.
22. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
23. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation 1994;89:503-5.
24. Stonãns I, Stonãne E, Ruâwurm S, Deiguer HP, Bõhm KJ, Wiederhold M et al. HepG2 Human hepatoma cells express multiple cytokines genes. Cytokine 1999;11:151-6.
25. Igaz P, Tóth S, Rose-John S, Madurka I, Fejér G, Szalai C et al. Soluble interleukin-6 receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Cytokine 1998;10:620-6.
26. Zhu J, Shearer GM, Norman JE, Pinto LA, Marincola FM, Prasad A et al. Host response of Cytomegalovirus infection as a determinant of susceptibility to coronary artery disease. Circulation 2000;102:2491-6.
27. Zhu J, Quyyumi AA, Norman JE, Csako G, Epstein SE. Cytomegalovirus in the pathogenesis of atherosclerosis. JACC 1999;34:1738-43.
28. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000;102:1917-23.
29. Depraetere S, Willems J, Joniau M. Stimulation of CRP secretion in HepG2 cells: Cooperative effect of dexamethasone and interleukin 6. Agents Actions 1991;34:3/4.
30. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989;8:3773-9.
31. Gabay C, Porter B, Guenette D, Billir B, Arend W. Interleukin-4 (IL-4) and Il-13 enhance the effect of Il-1B on production of Il-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: Differential effect on C-reactive protein production. Blood 1999;83:1299-307.
32. Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A et al. Chlamydia pneumoniae Infection of vascular smooth muscle and endothelial cells activates NF-B and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 1999;100:1369-73.
33. Vink A, Poppen M, Schoneveld AH, Roholl PJM, de Kleijn DPV, Borst C et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 2001;103:1613-7.